Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jenkner

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Pediatric Surgery|October 5, 2001
111 renal neoplasms of childhood: a clinicopathologic studyA Jenkner, F D Camassei, R Boldrini, et al.
Anti-Cancer Drugs|June 1, 1993
D-CECaT: a breakthrough for patients with neuroblastomaA Donfrancesco, G Deb, A Angioni, et al.
Bone Marrow Transplantation|January 26, 2010
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's HospitalI Ilari, M A De Ioris, G M Milano, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|June 5, 2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of ageA Donfrancesco, A Jenkner, A Castellano, et al.
Lymphology|January 24, 2022
Expanding the spectrum of Gorham Stout disease exploring a single center pediatric case seriesI Rana, P S Buonuomo, G Mastrogiorgio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Journal of Endocrinological Investigation|March 31, 2024
Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout diseaseM Rossi, S Terreri, G Battafarano, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Pediatric Surgery|October 5, 2001
111 renal neoplasms of childhood: a clinicopathologic studyA Jenkner, F D Camassei, R Boldrini, et al.
Anti-Cancer Drugs|June 1, 1993
D-CECaT: a breakthrough for patients with neuroblastomaA Donfrancesco, G Deb, A Angioni, et al.
Bone Marrow Transplantation|January 26, 2010
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's HospitalI Ilari, M A De Ioris, G M Milano, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|June 5, 2004
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of ageA Donfrancesco, A Jenkner, A Castellano, et al.
Lymphology|January 24, 2022
Expanding the spectrum of Gorham Stout disease exploring a single center pediatric case seriesI Rana, P S Buonuomo, G Mastrogiorgio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Journal of Endocrinological Investigation|March 31, 2024
Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout diseaseM Rossi, S Terreri, G Battafarano, et al.
Pageof 2